The Scientific Frontier

Pfizer

2 articles

A scientist in a futuristic lab examining a holographic display of a triple hormone receptor drug, representing Pfizer's new obesity treatment.
Cosmos & Physics

Pfizer advances monthly obesity drug targeting triple hormone receptors

Pfizer is advancing a monthly weight-loss injection, danuglipron, having announced positive early-stage data.

Dr. Evelyn Reed·June 7, 2026
Scientists in a futuristic lab analyzing bispecific antibody data, representing advancements in lung cancer treatment presented at ASCO.
Computational Science & Software

Pfizer Shares Updated Lung Cancer Bispecifics Data at ASCO

At the ASCO Annual Meeting, updated Phase 2 data for Pfizer's bispecific antibody PF-08634404 demonstrated activity as monotherapy in first-line PD-L1-expressing non-small cell lung cancer.

Yasmin Haddad·May 31, 2026